These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1330 related items for PubMed ID: 15740931
21. Diagnostic performance and cost effectiveness of measurements of plasma N-terminal pro brain natriuretic peptide in patients presenting with acute dyspnea or peripheral edema. Behnes M, Brueckmann M, Ahmad-Nejad P, Lang S, Wolpert C, Elmas E, Kaelsch T, Gruettner J, Weiss C, Borggrefe M, Neumaier M. Int J Cardiol; 2009 Jun 26; 135(2):165-74. PubMed ID: 18603317 [Abstract] [Full Text] [Related]
22. The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Januzzi JL, Camargo CA, Anwaruddin S, Baggish AL, Chen AA, Krauser DG, Tung R, Cameron R, Nagurney JT, Chae CU, Lloyd-Jones DM, Brown DF, Foran-Melanson S, Sluss PM, Lee-Lewandrowski E, Lewandrowski KB. Am J Cardiol; 2005 Apr 15; 95(8):948-54. PubMed ID: 15820160 [Abstract] [Full Text] [Related]
23. Role of the plasma brain natriuretic peptide in differentiating patients with congestive heart failure from other diseases. Sirithunyanont C, Leowattana W, Sukumalchantra Y, Chaisupamonkollarp S, Watanawaroon S, Chivatanaporn B, Bhuripanyo K, Mahanonda N. J Med Assoc Thai; 2003 May 15; 86 Suppl 1():S87-95. PubMed ID: 12866774 [Abstract] [Full Text] [Related]
24. Utility of amino-terminal pro-brain natriuretic peptide testing for prediction of 1-year mortality in patients with dyspnea treated in the emergency department. Januzzi JL, Sakhuja R, O'donoghue M, Baggish AL, Anwaruddin S, Chae CU, Cameron R, Krauser DG, Tung R, Camargo CA, Lloyd-Jones DM. Arch Intern Med; 2006 Feb 13; 166(3):315-20. PubMed ID: 16476871 [Abstract] [Full Text] [Related]
25. Head-to-head comparison of the diagnostic utility of BNP and NT-proBNP in symptomatic and asymptomatic structural heart disease. Mueller T, Gegenhuber A, Poelz W, Haltmayer M. Clin Chim Acta; 2004 Mar 13; 341(1-2):41-8. PubMed ID: 14967157 [Abstract] [Full Text] [Related]
26. [Personal experience with determination of NT-proBNP in clinical practice]. Stejskal D, Oral I, Lacnák B, Juráková R, Horalík D, Adamovská S, Prosková J, Hrabovská I, Ozanová G. Vnitr Lek; 2003 Feb 13; 49(2):121-6. PubMed ID: 12728579 [Abstract] [Full Text] [Related]
27. Plasma N-terminal pro-brain natriuretic peptide: a marker of left ventricular hypertrophy in hypertrophic cardiomyopathy. Brito D, Matias JS, Sargento L, Cabral MJ, Madeira HC. Rev Port Cardiol; 2004 Dec 13; 23(12):1557-82. PubMed ID: 15732658 [Abstract] [Full Text] [Related]
31. Admission NT-proBNP levels, renal insufficiency and age as predictors of mortality in elderly patients hospitalized for acute dyspnea. Reny JL, Millot O, Vanderecamer T, Vergnes C, Barazer I, Sedighian S, Berdagué P. Eur J Intern Med; 2009 Jan 13; 20(1):14-9. PubMed ID: 19237086 [Abstract] [Full Text] [Related]
33. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure. von Haehling S, Jankowska EA, Morgenthaler NG, Vassanelli C, Zanolla L, Rozentryt P, Filippatos GS, Doehner W, Koehler F, Papassotiriou J, Kremastinos DT, Banasiak W, Struck J, Ponikowski P, Bergmann A, Anker SD. J Am Coll Cardiol; 2007 Nov 13; 50(20):1973-80. PubMed ID: 17996563 [Abstract] [Full Text] [Related]
34. Utility of plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) to distinguish between congestive heart failure and non-cardiac causes of acute dyspnea in cats. Fox PR, Oyama MA, Reynolds C, Rush JE, DeFrancesco TC, Keene BW, Atkins CE, Macdonald KA, Schober KE, Bonagura JD, Stepien RL, Kellihan HB, Nguyenba TP, Lehmkuhl LB, Lefbom BK, Moise NS, Hogan DF. J Vet Cardiol; 2009 May 13; 11 Suppl 1():S51-61. PubMed ID: 19394287 [Abstract] [Full Text] [Related]
35. N-terminal pro-B-type natriuretic peptide is an independent predictor of outcome in an unselected cohort of critically ill patients. Meyer B, Huelsmann M, Wexberg P, Delle Karth G, Berger R, Moertl D, Szekeres T, Pacher R, Heinz G. Crit Care Med; 2007 Oct 13; 35(10):2268-73. PubMed ID: 17717488 [Abstract] [Full Text] [Related]
36. Comparison of B-type natriuretic peptides for assessment of cardiac function and prognosis in stable ischemic heart disease. Richards M, Nicholls MG, Espiner EA, Lainchbury JG, Troughton RW, Elliott J, Frampton CM, Crozier IG, Yandle TG, Doughty R, MacMahon S, Sharpe N, Christchurch Cardioendocrine Research Group, Australia-New Zealand Heart Failure Group. J Am Coll Cardiol; 2006 Jan 03; 47(1):52-60. PubMed ID: 16386664 [Abstract] [Full Text] [Related]
39. Relationship between N-terminal pro-B-type natriuretic peptide plasma levels and renal function evaluated with different formulae in older adult subjects admitted because of dyspnea. Fabbian F, De Giorgi A, Portaluppi F, Zuliani G. Gerontology; 2012 Jan 03; 58(1):50-5. PubMed ID: 21540563 [Abstract] [Full Text] [Related]
40. B-type natriuretic peptide (BNP) is more sensitive to rapid hemodynamic changes in acute heart failure than N-terminal proBNP. Mair J, Falkensammer G, Poelzl G, Hammerer-Lercher A, Griesmacher A, Pachinger O. Clin Chim Acta; 2007 Apr 03; 379(1-2):163-6. PubMed ID: 17258185 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]